New research progress of miR-144 in cardiovascular diseases
release_mhb6xi6cdvfyjdmsy2bgpbdabq
by
Ming-Ren Ma,
Fei Wang,
Wei Hu,
Xiao-Qing Cai,
Peng Zhang,
Bin Yuan,
Ling Ma
2020 Volume 45, p888-892
Abstract
MicroRNA is a type of widely distributed endogenous small single-stranded non-coding RNA that regulates important biological processes. It complements the target mRNA sequence, degrades the target mRNA and inhibits protein translation, and plays a regulatory role at the transcription level. Studies have confirmed that microRNAs in circulation are present in various body fluids in a stable form and can be used as biomarkers of disease. miR-144 is highly conservative in structure, exists in the form of miR-144/miR-451 gene cluster in the genome, and participates in the occurrence and development of erythroid differentiation, tumors, and cardiovascular diseases. With the continuous progress of life sciences, miR-144 pathogenic mechanism and role in cardiovascular disease have been gradually revealed. This article gathers the relationship between miR-144 and the pathogenesis of cardiovascular disease and the diagnosis and treatment plan, starting from the relationship between miR-144 and coronary atherosclerotic heart disease, arrhythmia and structural heart disease, combing related research progress, with a view to providing new ideas and methods for the diagnosis and treatment of cardiovascular diseases.
DOI: 10.11855/j.issn.0577-7402.2020.08.17
In text/plain
format
Archived Files and Locations
application/pdf
759.8 kB
file_wswb6afkb5aljaphsk6sesbdey
|
www.plamj.org (publisher) web.archive.org (webarchive) |
access all versions, variants, and formats of this works (eg, pre-prints)